The DOI matches its Crossref record; 93 of the 95 references it cites were found in a registry or an index.
Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
Open accessAbstract
This review critically appraises studies examining the association of novel factors with diabetes. We show that many of the most studied novel and apparently 'independent' risk factors are correlated with each other by virtue of their common origins or pathways, and that residual confounding is likely. Available studies also have other limitations, including differences in methodology or inadequate statistical analyses. Furthermore, although most relevant work in this area has focused on improving our understanding of the pathogenesis of diabetes, association studies in isolation cannot prove causality; intervention studies with specific agents (if available) are required, and genetic studies may help. With respect to the potential value of novel risk factors for diabetes risk prediction, we illustrate why this work is very much in its infancy and currently not guaranteed to reach clinical utility. Indeed, the existence of several more easily measured powerful predictors of diabetes, suggests that the additional value of novel markers may be limited. Nevertheless, several suggestions to improve relevant research are given. Finally, we show that several risk factors for diabetes are only weakly associated with the risk of incident vascular events, an observation that highlights the limitations of attempting to devise unified criteria (e.g. metabolic syndrome) to identify individuals at risk of both CHD and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“insulin resistance and ectopic and total fat (HOMA-IR). 2,29-31”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“liver adiposity in addi tion to alcohol intake signals (GGT)”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“consistent with their roles as biomarkers reflecting total obesity or percent fat mass (leptin)”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0298 · Cited by 2,048
Lindström, J., & Tuomilehto, J. O. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.725 · Cited by 1,937
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,782
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Cited by
Sorted by citations
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Self-citationDiabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,455
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Diabetes Mellitus and Inflammation
Lontchi‐Yimagou, E., Sobngwi, E., Matsha, T. E., & Kengne, A. P. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0375-y · Cited by 832
The role of diet in the prevention of type 2 diabetes
Salas‐Salvadó, J., Martínez‐González, M. Á., Bulló, M., & Ros, E. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.03.009 · Cited by 357
Preiss, D., & Sattar, N. A. (2008) · Clinical Science · doi:10.1042/cs20070402 · Cited by 297
Self-citationWannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., & Sattar, N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2 · Cited by 281
Self-citationTamayo, T., Rosenbauer, J., Wild, S. H., Spijkerman, A. M. W., Baan, C. A., Forouhi, N. G., Herder, C., & Rathmann, W. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.007 · Cited by 268
Self-citationMetabonomic, transcriptomic, and genomic variation of a population cohort
Inouye, M., Kettunen, J., Soininen, P., Silander, K., Ripatti, S., Kumpula, L. S., Hämäläinen, E., Jousilahti, P., Kangas, A. J., Männistö, S., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.93 · Cited by 250
Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
Qi, X.-Y., Qu, S.-L., Xiong, W., Rom, O., Chang, L., & Jiang, Z. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0777-x · Cited by 239
An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study
Yuan, S., & Larsson, S. C. (2020) · Diabetologia · doi:10.1007/s00125-020-05253-x · Cited by 242
Wannamethee, S. G., Papacosta, O., Lawlor, D. A., Whincup, P. H., Lowe, G. D. O., Ebrahim, S. B. J., & Sattar, N. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2284-4 · Cited by 224
Self-citationType 2 diabetes as a disease of ectopic fat?
Sattar, N. A., & Gill, J. M. R. (2014) · BMC Medicine · doi:10.1186/s12916-014-0123-4 · Cited by 223
Self-citationTwo Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Kahn, H. S., Cheng, Y. J., Thompson, T. J., Imperatore, G., & Gregg, E. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00002 · Cited by 204
Badawi, A. F. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s9089 · Cited by 228
Savvidou, M. D., Nelson, S. M., Makgoba, M., Messow, C., Sattar, N. A., & Nicolaides, K. H. (2010) · Diabetes · doi:10.2337/db10-0688 · Cited by 181
Self-citationAnti‐inflammatory cytokines and risk of type 2 diabetes
Herder, C., Carstensen, M., & Ouwens, D. M. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12155 · Cited by 172
Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
Salomaa, V. V., Havulinna, A. S., Saarela, O., Zeller, T., Jousilahti, P., Jula, A. M., Münzel, T. F., Aromaa, A., Evans, A., Kuulasmaa, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010100 · Cited by 167
Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
Herder, C., Karakas, M., & Köenig, W. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.93 · Cited by 168
Periodontal Disease and Incident Diabetes
Ide, R., Hoshuyama, T., Wilson, D., Takahashi, K., & Higashi, T. (2010) · Journal of Dental Research · doi:10.1177/0022034510381902 · Cited by 149
Owen, C. G., Nightingale, C. M., Rudnicka, A. R., Sattar, N. A., Cook, D. G., Ekelund, U., & Whincup, P. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1781-1 · Cited by 146
Self-citationWannamethee, S. G., Whincup, P. H., Thomas, M. C., & Sattar, N. A. (2009) · Diabetes Care · doi:10.2337/dc09-0477 · Cited by 135
Self-citationMetabolic profiling of gestational diabetes in obese women during pregnancy
White, S. L., Pasupathy, D., Sattar, N. A., Nelson, S. M., Lawlor, D. A., Briley, A. L., Seed, P. T., Welsh, P. I., & Poston, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4380-6 · Cited by 135
Self-citationBozorgmanesh, M., Hadaegh, F., & Azizi, F. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-45 · Cited by 113
Iliodromiti, S., Sassarini, J., Kelsey, T., Lindsay, R. S., Sattar, N. A., & Nelson, S. M. (2016) · Diabetologia · doi:10.1007/s00125-015-3855-6 · Cited by 116
Self-citationPeriodontitis and incident type 2 diabetes: a prospective cohort study
Winning, L., Patterson, C., Neville, C. E., Kee, F., & Linden, G. J. (2016) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12691 · Cited by 99
Herder, C., Baumert, J., Zierer, A., Roden, M., Meisinger, C., Karakas, M., Chambless, L. E., Rathmann, W., Peters, A., Köenig, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019852 · Cited by 93
Qiu, G., Zheng, Y., Wang, H., Sun, J., Ma, H., Xiao, Y., Li, Y., Yuan, Y. L., Yang, H., Li, X., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw221 · Cited by 89
White, S. L., Lawlor, D. A., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng‐Ntim, E., Robson, S. C., Sattar, N. A., Seed, P. T., Vieira, M. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167846 · Cited by 80
Self-citationRebnord, E. W., Strand, E., Midttun, Ø., Svingen, G. F. T., Christensen, M. H. E., Ueland, P. M., Mellgren, G., Njølstad, P. R., Tell, G. S., Nygard, O. K., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4329-9 · Cited by 80
Nightingale, C. M., Rudnicka, A. R., Owen, C. G., Wells, J. C. K., Sattar, N. A., Cook, D. G., & Whincup, P. H. (2013) · Diabetes Care · doi:10.2337/dc12-1726 · Cited by 76
Self-citationRathmann, W., Kowall, B., Heier, M., Herder, C., Holle, R., Thorand, B., Strassburger, K., Peters, A., Wichmann, H. ‐., Giani, G., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03065.x · Cited by 74
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T. M., Preiss, D., Sattar, N. A., Fraser, A., & Waugh, N. R. (2011) · Health Technology Assessment · doi:10.3310/hta15380 · Cited by 76
Self-citationJacobs, S., Boushey, C. J., Franke, A. A., Shvetsov, Y. B., Monroe, K. R., Haiman, C. A., Kolonel, L. N., Marchand, L. L., & Maskarinec, G. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002033 · Cited by 72
Prajapati, B., Jena, P. K., Rajput, P., Purandhar, K., & Seshadri, S. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140515112609 · Cited by 70
Rückert, I., Heier, M., Rathmann, W., Baumeister, S. E., Döring, A., & Meisinger, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022932 · Cited by 70
The potential of novel biomarkers to improve risk prediction of type 2 diabetes
Herder, C., Kowall, B., Tabák, Á. G., & Rathmann, W. (2013) · Diabetologia · doi:10.1007/s00125-013-3061-3 · Cited by 70
Teichert, T., Vossoughi, M., Vierkötter, A., Sugiri, D., Schikowski, T., Schulte, T., Roden, M., Luckhaus, C., Herder, C., & Krämer, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083042 · Cited by 69
Abbasi, A., Sahlqvist, A., Lotta, L. A., Brosnan, J. M., Vollenweider, P., Giabbanelli, P. J., Nunez, D. J., Waterworth, D. M., Scott, R. A., Langenberg, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163721 · Cited by 65
Miller, A. M., Purves, D. G., McConnachie, A., Asquith, D. L., Batty, G. D., Burns, H., Cavanagh, J., Ford, I., McLean, J. S., Packard, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047830 · Cited by 66
Self-citationAdiponectin, Diabetes, and Coronary Heart Disease in Older Persons: Unraveling the Paradox
Sattar, N. A., & Nelson, S. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1435 · Cited by 63
Self-citationCirculating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes
Su, S., Pei, D., Hsieh, C., Hsiao, F., Wu, C., & Hung, Y.-J. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0171-y · Cited by 59
Paradisi, G., Ianniello, F., Tomei, C., Bracaglia, M., Carducci, B., Gualano, M. R., Torre, G. L., Banci, M., & Caruso, A. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003632084 · Cited by 54
Economou, F., Xyrafis, X., Livadas, S., Androulakis, I. I., Argyrakopoulou, G., Christakou, C. D., Kandaraki, E., Palioura, E., & Diamanti‐Kandarakis, E. (2009) · HORMONES · doi:10.14310/horm.2002.1236 · Cited by 51
Montonen, J., Drogan, D., Joost, H., Boeing, H., Fritsche, A., Schleicher, E. D., Schulze, M. B., & Pischon, T. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9539-0 · Cited by 51
Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
McKillop, A., & Flatt, P. (2011) · Diabetes Care · doi:10.2337/dc11-0837 · Cited by 48
Sattar, N. A. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03480.x · Cited by 50
Self-citationSystems Metabolomics for Prediction of Metabolic Syndrome
Pujos‐Guillot, E., Brandolini, M., Pétéra, M., Grissa, D., Joly, C., Lyan, B., Herquelot, É., Czernichow, S., Zins, M., Goldberg, M., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00116 · Cited by 51
Raynor, L. A., Pankow, J. S., Duncan, B. B., Schmidt, M. I., Hoogeveen, R. C., Pereira, M. A., Young, J. H., & Ballantyne, C. M. (2012) · Diabetes Care · doi:10.2337/dc12-0609 · Cited by 46
Maitland, R., Seed, P. T., Briley, A. L., Homsy, M., Sanders, T. A. B., Pasupathy, D., Robson, S. C., Nelson, S. M., Sattar, N. A., & Poston, L. (2014) · Diabetic Medicine · doi:10.1111/dme.12482 · Cited by 46
Self-citationAlessi, M., Nicaud, V., Scroyen, I., Lange, C., Saut, N., Fumeron, F., Marre, M., Lantieri, O., Fontaine‐Bisson, B., Juhan-Vague, I., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-03-0179 · Cited by 42
and the NSHD Scientific and Data Collection team, Murray, E. T., Hardy, R., Hughes, A. D., Wills, A. K., Sattar, N. A., Deanfield, J. E., Kuh, D. J., & Whincup, P. H. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.19 · Cited by 42
Self-citationJacobs, S., Kroeger, J., Schulze, M. B., Frank, L. K., Franke, A. A., Cheng, I. C., Monroe, K. R., Haiman, C. A., Kolonel, L. N., Wilkens, L. R., et al. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.000620 · Cited by 40
Echouffo-Tcheugui, J. B., Dieffenbach, S. D., & Kengne, A. P. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.023 · Cited by 38
Vascular function and cardiovascular risk factors in women with severe flushing
Sassarini, J., Fox, H., Ferrell, W. R., Sattar, N. A., & Lumsden, M. A. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03921.x · Cited by 38
Self-citationThe Association of Smoking and Diabetes With Periodontitis in a Korean Population
Han, D., Lim, S., & Kim, J. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.110686 · Cited by 36
Julia, C., Czernichow, S., Charnaux, N., Ahluwalia, N., Andreeva, V. A., Touvier, M., Galan, P., & Fezeu, L. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.001 · Cited by 39
Horsch, A., Gilbert, L., Lanzi, S., Gross, J., Kayser, B., Vial, Y., Siméoni, U., Hans, D. B., Berney, A., Scholz, U., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020462 · Cited by 37
Ceramides: A new player in the inflammation–insulin resistance paradigm?
Gill, J. M. R., & Sattar, N. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1546-x · Cited by 36
Self-citationEmerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review
Bogdanet, D., Reddin, C., Murphy, D., Doheny, H. C., Halperin, J. A., Dunne, F., & O’Shea, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071533 · Cited by 33
Goldberg, R. B., Bray, G. A., Marcovina, S. M., Mather, K. J., Orchard, T. J., Perreault, L., & Temprosa, M. G. (2018) · Diabetologia · doi:10.1007/s00125-018-4748-2 · Cited by 31
Zoppini, G., Bonapace, S., Bergamini, C., Rossi, A., Trombetta, M., Lanzoni, L. D. A., Bertolini, L., Zenari, L., Bonora, E., & Targher, G. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.05.004 · Cited by 28
Yates, T. E., Davies, M. J., Gorely, T., Talbot, D. C. S., Bull, F., Sattar, N. A., & Khunti, K. K. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03091.x · Cited by 27
Self-citationBromelain supplementation and inflammatory markers: A systematic review of clinical trials
Pereira, I. C., Vieira, E. E. S., Torres, L. R. D. O., da Silva, F. C. C., Sousa, J. M. D. C. E., & Torres‐Leal, F. L. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.02.028 · Cited by 28
Yan, G., Li, F. R., Elia, C., Zhao, Y., Wang, J., Chen, Z., Yuan, H., & Lu, Y. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0399-7 · Cited by 24
Peters, M. J. L., Ghouri, N., McKeigue, P., Forouhi, N. G., & Sattar, N. A. (2012) · Cytokine · doi:10.1016/j.cyto.2012.09.002 · Cited by 26
Self-citationThe impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitus
Nair, A. T. N., Donnelly, L. A., Dawed, A. Y., Gan, S., Anjana, R. M., Mohan, V., Palmer, C. N. A., & Pearson, E. R. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.108 · Cited by 23
Roche, E., Ramírez-Tortosa, C. L., Arribas, M. I., Ochoa, J. J., Sirvent-Belando, J. E., Battino, M. A., Ramírez-Tortosa, M. C., González-Alonso, A., Pérez-López, M. P., & Quiles, J. L. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt157 · Cited by 23
Lepedda, A. J., Lobina, O., Rocchiccioli, S., Nieddu, G., Ucciferri, N., Muro, P. D., U, I. M., Nguyen, H. Q. T., Guarino, A., Spirito, R., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.007 · Cited by 22
Schulze, M. B., & Hu, F. B. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_66 · Cited by 20
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
for the Prospective Study of Pravastatin in the Elderly at Risk Trial Study Group, Sattar, N., Murray, H. M., Welsh, P., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1217-3 · Cited by 19
Self-citationTriglycerides and coronary heart disease: have recent insights yielded conclusive answers?
Sarwar, N., & Sattar, N. A. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832dd4dc · Cited by 18
Self-citationGonzález-Alonso, A., Ramírez-Tortosa, C. L., Varela‐López, A., Roche, E., Arribas, M. I., Ramírez-Tortosa, M. C., Giampieri, F., Ochoa, J. J., & Quiles, J. L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023425 · Cited by 19
Poston, L., Bell, R., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng‐Ntim, E., Sandall, J., Sanders, T. A. B., Sattar, N. A., Seed, P. T., et al. (2017) · Programme Grants for Applied Research · doi:10.3310/pgfar05100 · Cited by 19
Self-citationHome-based exercise for middle-aged Chinese at diabetic risk: A randomized controlled trial
Wu, Y.-T., Hwang, C., Chen, C., & Chuang, L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.02.018 · Cited by 20
Influence of Gut Microbiota on Inflammation and Pathogenesis of Sugar Rich Diet Induced Diabetes
Jena, P. K., & Prajapati, B. (2016) · Immunome Research · doi:10.4172/1745-7580.10000109 · Cited by 18
Wu, H., Yu, Z., Qi, Q., Li, H., Sun, Q., & Lin, X. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000191 · Cited by 18
Amylidi-Mohr, S. K., Lang, C., Mosimann, B., Fiedler, M., Stettler, C., Surbek, D., & Raio, L. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14495 · Cited by 19
Cho, A., Lee, S., Hong, K., & Jung, D. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01755-1 · Cited by 16
Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes
Ramachandran, S., & Kartha, C. S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-038 · Cited by 16
Somerset, S. M., Graham, L., & Markwell, K. (2013) · e-SPEN Journal · doi:10.1016/j.clnme.2013.02.003 · Cited by 14
Pan, J., Ding, Y., Sun, Y., Li, Q., Wei, T., Gu, Y., Zhou, Y., Pang, N., Pei, L., Ma, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062126 · Cited by 13
Welsh, P. I., Packard, C. J., & Sattar, N. A. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32831551e0 · Cited by 14
Self-citationRelationships between Follicle-Stimulating Hormone and Adiponectin in Postmenopausal Women
Huang, W., Chen, D., Kor, C., Chen, T., Lin, P., Tseng, J. T.-C., & Wu, H. (2020) · Metabolites · doi:10.3390/metabo10100420 · Cited by 13
Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
Viggiano, D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216848 · Cited by 12
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 14
Lipid accumulation product and type 2 diabetes risk: a population-based study
Sadafi, S., Azizi, A., Najafi, F., & Pasdar, Y. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01682-6 · Cited by 11
Pak, J., Kwon, Y., Menzo, E. L., Park, S. S., Szomstein, S., & Rosenthal, R. J. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.008 · Cited by 11
Liu, Y., Wang, W., Zou, Z., Sun, B., Liang, B., & Zhang, A. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114208 · Cited by 11
Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx® Diabetes Risk Score
Kolberg, J. A., Gerwien, R. W., Watkins, S. M., Wuestehube, L. J., & Urdea, M. S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.63 · Cited by 11
Quotah, O. F., Poston, L., Flynn, A. C., & White, S. L. (2022) · Metabolites · doi:10.3390/metabo12100922 · Cited by 11
The correlation between testosterone, inflammation and cytokine status in type‐2 diabetes men
Sheikh‐Ahmad, M., Nakhleh, A., Riskin, A., Yovanovich, E., Chen‐Konak, L., Reut, M., & Saiegh, L. (2022) · Andrologia · doi:10.1111/and.14526 · Cited by 10
Propolis restored adiponectin level in type 2 diabetes through PPARγ activation
Eissa, L. A., Elsherbiny, N. M., & Magmomah, A. O. (2015) · Egyptian Journal of Basic and Applied Sciences · doi:10.1016/j.ejbas.2015.06.003 · Cited by 10
Darabi, H., Raeisi, A., Kalantarhormozi, M., Ostovar, A., Assadi, M., Asadipooya, K., Vahdat, K., Dobaradaran, S., & Nabipour, I. (2015) · Medicine · doi:10.1097/md.0000000000001347 · Cited by 9
Update on the Treatments of Non-Alcoholic Fatty Liver Disease (NAFLD)
Quercioli, A., Montecucco, F., & Mach, F. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x10909040261 · Cited by 10
Adiponectin is associated with insulin sensitivity in white European men but not black African men
Hakim, O., Bello, O., Ladwa, M., Shojaee‐Moradie, F., Jackson, N., Peacock, J. L., Umpleby, A. M., Charles‐Edwards, G., Amiel, S. A., & Goff, L. M. (2021) · Diabetic Medicine · doi:10.1111/dme.14571 · Cited by 8
Adipocytokine Associations with Insulin Resistance in British South Asians
Webb, D. R., Khunti, K. K., Chatterjee, S., Jarvis, J., & Davies, M. J. (2013) · Journal of Diabetes Research · doi:10.1155/2013/561016 · Cited by 7
Biochemical Biomarkers-Independent Predictors of Type 2 Diabetes Mellitus
Cheekurthy, A. J. (2015) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000121 · Cited by 7
Metadata
- Authors
- Sattar, N., Wannamethee, S. G., & Forouhi, N. G.
- Affiliations
- University of Glasgow (GB)
- The Royal Free Hospital (GB)
- Addenbrooke's Hospital (GB)
- Corresponding author
- Sattar, N.
- Venue
- Diabetologia
- Published
- 2008-04-08
- Volume
- 51
- Issue
- 6
- Pages
- 926-940
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2098783546
- Cited by
- 143
- References
- 95
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 10 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 7 · 2016: 11 · 2015: 12 · 2014: 6 · 2013: 16 · 2012: 8
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation
- Diabetes UK
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, novel risk factors, diabetes pathogenesis, residual confounding, causality, genetic research, diabetes risk prediction, metabolic syndrome, cardiovascular risk, coronary artery disease, vascular events
- MeSH terms
- Alanine Transaminase, Diabetes Mellitus, Type 2, Endothelium, Vascular, gamma-Glutamyltransferase, Humans, Inflammation, Predictive Value of Tests, Risk, Risk Factors, Biomarkers, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
